The first part of this Review, which included a general introduction and the discussion of gastro-intestinal, cutaneous and genito-urinary non-Hodgkin's lymphomas, was published in a previous issue of this journal (Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Annals of Oncology 1997; 8(8): 727-37). We do not discuss again here the general problems posed by the extranodal presentation of non-Hodgkin's lymphomas. However, it is important to remember that the fundamental contribution of the R.E.A.L. Classification [4] in recognising different lymphoma entities can be the basis to improve our knowledge in extranodal lymphomas as well as in the nodal ones. However, at least thus far, treatment approaches are more influenced by the histologic type than the presenting site, thus emphasising how essential is a precise pathologic diagnosis.
The above mentioned Part 1 also contained the first part of the bibliography (References 1-101) and the first six tables.
D. Head and neck lymphoma
In the light of the current understanding of lymphoma biology [4] , it is evident that considering all the lymphomas arising in the head and neck region as a single group is simply the heritage of a historical topographical distinction, related to the fact that this anatomic region is the second most common site of localised extranodal presentation of non-Hodgkin's lymphoma. However it is now clear that different lymphoma entities can arise within the head and neck area. The localisation of tumour presentation by site reveals tonsil to be the most common, followed by nasopharynx, oral cavity, salivary glands, paranasal sinuses and base of tongue. At the end of this section we will also discuss thyroid and orbital lymphomas, even though they are not usually considered with head and neck lymphomas.
The signs and symptoms of a non-Hodgkin's lymphoma may be similar to those of a head and neck squamous cancer, and only by biopsy can the distinction be made. Long-term results in patients presenting with extranodal lymphomas in the head and neck area vary greatly, depending not only on histology, but also on sites of presentation. In a series of 156 patients with head and neck lymphomas, the five-year survival according to site was as follows: salivary gland (61%), oral cavity (57%), tonsil (49%), base of tongue (47%), nasopharynx (36%), and paranasal sinuses (12%) [102] . One problem related to most sites in the head and neck area is the precise definition of disease bulk. Recent advances in imaging, particularly CT and MRI, have greatly facilitated the definition of disease extent, even though documentation of precise margins remains difficult for some localisations (e.g., paranasal sinus) [12, 103] .
Primary lymphomas of the Waldeyer's ring (tonsil, base of tongue and nasopharynx)
As stated earlier, there is controversy as to whether tonsils and Waldeyer's ring in general should be considered as nodal or extranodal sites. The tonsil resembles MALT in its relation to the pharyngeal epithelium and its lack of afferent lymphatics, but its overall structure, lack of prominent marginal zone, predominant IgG as opposed to IgA secretion by its resident plasma cells are more characteristic of peripheral lymph nodes [11] . More than 70% of primary tonsillary NHLs are of diffuse large B-cell type. Lymphomas of MALT type are uncommon in the tonsil; among low-grade tonsillary NHLs; follicular lymphoma is quite common in contrast to the gut where it is very rare. Lymphoblastic (either of B-or T-cell type) and Burkitt's lymphoma, commonly affecting palatine tonsil and paranasal sinuses, are almost exclusively found in paediatric patients [8, 11] (Table 7) . About half of the Waldeyer's ring NHLs arise in the palatine tonsil and about 20% of them are bilateral. Full staging procedures are mandatory, since about one of three patients presenting with tonsiliar lymphomas have disseminated disease. An important aspect of the natural history of Waldeyer's ring lymphoma is its relationship to GI tract involvement, either concurrent with diagnosis or at subsequent relapse [104] . Therefore, GI tract investigation belongs to the required staging procedure in cases with apparently localised tonsil presentations. The GI tract is clearly also the most common extranodal site of disease progression [9] , Their treatment might be based on what we know from the therapy of lymphomas of nodal origin since nodal type histologies are predominant. However, indications for local radiotherapy might be more stringent for these lymphomas than for nodal lymphomas in general [102] : a combined modality approach, using an antracycline-based chemotherapy regimen followed by radiation therapy (35-40 Gy) to the primary site and neck nodes is the most common approach. Overall survival at five years is approximately 60% to 75% [12] . There is no indication for central nervous system (CNS) prophylaxis in stage I-II disease.
Salivary gland lymphoma and other lymphomas of the oral cavity
The vast majority of lymphomas in the oral cavity are of intermediate-or high-grade malignancy, with follicular lymphomas representing only 15%-20% of the cases [8, 105, 106] . However, in the salivary glands, about half of the patients have low-grade B-cell lymphomas of MALT type that seem to have arisen against a background of chronic inflammation due to the myo-epithelial sialadenitis (MESA) often associated with Sjogren's syndrome. Whether some (and if so what percentage) of the high-grade lymphomas are also of MALT origin remains to be determined [8, 107, 108] .
The most frequently described localisations are the hard palate, the gingiva, the buccal mucosa, and the salivary glands [105, 106] . Most of the knowledge acquired concerns lymphomas of salivary glands, the vast majority of which are located in the parotid. Salivary gland lymphomas account for 5%-10% of all salivary gland tumours and somewhat less than 5% of lymphomas at all sites [1, 23] . Several studies of large numbers of patients undergoing parotidectomy have reported a l%-4% incidence of lymphoma.
However, the true incidence of primary lymphomas of the salivary glands is difficult to estimate because of the presence within the parotid gland of lymph nodes from which nodal lymphomas may arise, despite classification as extranodal. This is often the case for follicular lymphomas and lymphocytic lymphoma (B-CLL) of the parotid gland and for lymphomas with high-grade histology [8] . The presence of nodal lymphoid tissue inside salivary gland may also explain the conflicting cytogenetic data regarding the presence in salivary gland lymphomas of the t(14;18)(q32;q21) translocation that is characteristic of follicular lymphoma [8, 12, 109] .
Survival statistics vary greatly from series to series, with a reported long-term survival of 50%-75% [12, 108] . Overall, the survival rates quoted for most series are higher than for most other localisations of extranodal lymphoma.
There are few therapeutic rules concerning primary localisation in the palate and gingival; mutilating surgery should be avoided and a combination of chemotherapy and radiotherapy should be applied, depending on the histologic subtype [105] . The role of surgery in salivary gland lymphoma should be limited to excisional biopsy, while further therapy has to be tailored to stage and especially histologic subtype (local radiotherapy alone for localised low-grade lymphomas or combined modality approaches using doxorubicin-containing regimens and local radiation for aggressive histologies) [12] .
Nasal angiocentric T/NK-cell lymphoma and other lymphomas of the nasal and paranasal region
Primary lymphoma of the paranasal sinuses and of the nasal cavity comprises a controversial subset of malignant lymphomas, owing in part to the difficulty of recognising them, both clinically and pathologically. Their incidence is difficult to ascertain, given the problems with recognition, the tendency to group these uncommon lymphomas with those arising in adjacent structures and the variation in incidence among different populations. These lymphomas appear to be exceedingly rare in Western countries, where they usually show a B-cell phenotype, but relatively common among Asians and Native Americans of Central and South America, suggesting a racial predisposition [110] . Indeed, in Asian countries they represent the second largest group of extranodal lymphomas after GI localisations, and most of them have a T/NK-cell phenotype [110] . Most cases present with a destructive nasal or midline facial lesion, erythema, and swelling and oedema can be prominent [110] . This category of lymphoma has been referred to in the past as lethal midline granuloma and, more recently, as angiocentric T/NK-cell nasal lymphoma. Histologically, the lymphoma characteristically shows a broad spectrum of cell size, and is associated with features of angiocentric and angiodestructive growth and extensive necrosis [4, 110, 111] . In early stages, there can be a prominent inflammatory background, often causing difficulty in differentiating it from an inflammatory or infectious process [110] . The most common immunophenotype is CD56+ (a natural killer cell antigen which would suggest a natural killer cell derivation), CD2+, surface CD3-but cytoplasmic CD3+ [110, 111] . T-cell receptor antigen gene rearrangements are usually not demonstrable [110, 112] . EBV sequences can be identified in virtually all cases, strongly suggesting that EBV may play an important role in the pathogenesis of this disease [111] [112] [113] [114] [115] .
Although nasal T/NK-cell lymphoma thus appears to be a distinctive type of neoplasm, lymphomas with similar characteristics have on rare occasions been identified at other sites. In addition to the nasal cavity and the nasal sinuses it has been described in other locations in the upper aerodigestive tract, including the nasopharynx, the oropharynx and the larynx [9, 110] . Rare cases of nasal-type T/NK-cell lymphoma may present in the skin, soft tissues, in the gastrointestinal tract and in t h e t e s t i s [110, 111] .
In Western countries, as stated before, the majority of cases arising in the nasal region are intermediate or high-grade B-cell lymphomas [116, 117] . It has been noted that the B-cell phenotype is predominant in the paranasal sinus localisation, whilst T-cell immunophenotypic expression is typical of the nasal lymphoma [118] . Recent reports have emphasised the tendency of paranasal lymphomas to present with bulky localised disease, to relapse in non-contiguous nodal and extranodal sites after radiation therapy, and to frequently spread to the central nervous system [9, 23, 102, 104, 110, 117] . The local bulkiness of the disease at the time of diagnosis in nasal and paranasal sinus lymphomas may be related to their origin in and growth into clinically silent sites such as the sinuses, the parapharyngeal space or the infratemporal fossa. In addition, because lymph node involvement is uncommon, most patients present only after locally advanced disease has caused pain, nasal obstruction, or facial distortion. Thus, the TNM staging system, which describes accurately the extent of local disease, may be used in addition to the Ann Arbor staging system [9, 23, 102-104, 117, 119] .
In the past, treatment results in patients with paranasal sinus lymphoma have been dismal, with a five-year survival of only 12%-15% [102] . Among patients treated with radiation therapy alone the systemic recurrence rate is relevant (approximately half of the cases, generally within the first year after irradiation) despite excellent local control [110] . No clear predilection for gastrointestinal relapses has been described, and the parameningeal anatomic location of the paranasal sinus lymphomas explains the high risk for leptomeningeal relapse reported in some series [117] . Recently, therefore, a combined approach including systemic anthracyclinecontaining chemotherapy and involved field irradiation has become the standard treatment for B-cell lymphomas presenting in the nasal cavity or paranasal sinuses [117, 119, 120] .
Treatment of T/NK-cell nasal lymphoma in the literature has been inconsistent, with some groups using localised radiotherapy alone, and others multiagent chemotherapy with or without additional radiation therapy. Prognosis is usually poor once dissemination occurs. Reports on long-term results are very sparse and inconclusive; about one-half of the patients succumb to the disease [110, 111] . The hemophagocytic syndrome (hepatosplenomegaly, liver function abnormalities, thrombocytopenia, and erythrophagocytosis) is a common clinical complication which adversely affects survival in nasal T/NK-cell lymphoma [118] , and EBV probably plays a role in its pathogenesis [110] .
Primary lymphoma of the ocular adnexa (orbital lymphoma)
The term of primary lymphoma of the ocular adnexa refers to the lymphoma arising in the extraocular orbital space, involving either the anterior compartment of the orbital cavity (the eyelids, the lachrymal gland and the conjunctiva) or the posterior (retrobulbar) compartment.
Orbital lymphoma is considerably more common than intraocular lymphoma (lymphoma of the eye), accounting for about l%-2% of all lymphomas [9, 12, 23]. The two types of presentation should be clearly distinguished because of their different natural histories: the intraocular lymphoma is a subset of primary CNS lymphoma. Traditional histopathological classification has proven complex; presently, however, it seems that most low-grade cases can be considered to be of MALT origin [8, 121] . Only a minority of orbital lymphomas are intermediate-or high-grade, while most of them have a low-grade histology. This may be reflected in the 60%-75% 10-year survival rates reported for most series [23, [122] [123] [124] .
Treatment should be designed to cure, and extensive surgery must be avoided. Radiation therapy has been the common form of treatment for primary orbital lymphoma and high local control rates can be achieved with moderate-dose irradiation (25-35 Gy) [12, 91, 124] . At this dosage, visual complications are limited, but doses above 35 Gy result in an increased risk of complications. A correct imaging approach, including ultrasound, CT MRI and/or CTscan, to the orbital region is essential in the planning of the target volume [12, 103] . About 1/3 to 1/4 of the patients will progress in either the controlateral orbit or with systemic disease after local radiotherapy. It appears that retrobulbar involvement carries a higher risk of disease failure than anterior compartment disease [124] . So far there is little data to indicate that combined modality therapy should be applied, although this should be considered in the few patients showing an aggressive histology subtype [9, 91, 124] . In most instances, however, primary orbital lymphoma should still be handled with low-dose radiotherapy only, even if single-agent chemotherapy seems to be a valid alternative [122, 123] .
Thyroid lymphoma
Primary thyroid lymphoma is uncommon, accounting for only 5% of thyroid neoplasms and less than 2% of extranodal lymphomas [1] . The majority of patients have diffuse large B-cell lymphoma [125] , which clinically is often reflected by a rapidly enlarging neck mass accompanied by compression of surrounding structures such as the larynx or the oesophagus [103] . Elderly women are most often affected, perhaps because of the tendency of this neoplasm to occur against a background of Hashimoto's thyroiditis [126, 127] . The prevalence of aggressive histologies in most series may appear somewhat surprising, since most thyroid lymphomas are thought to arise from the MALT acquired in the course of Hashimoto's thyroiditis [8, 127] , and it has been proposed that all of the thyroid lymphomas could be considered of MALT derivation [8] . Indeed, transformation of low-grade MALT lymphomas to high-grade lesions can be documented, and, unlike other high-grade MALT lymphomas, lymphoepithelial lesions are often present also in high-grade tumours of the thyroid [8] .
The optimal treatment of thyroid lymphoma is no longer controversial, since the combination of anthracycline-based chemotherapy and irradiation is currently considered as the most appropriate approach. Surgery was used extensively in older studies, but since the introduction of thyroid biopsy and fine-needle aspiration, surgery has ceased to play a major role and debulking surgery should in any case be discouraged [9, 12, 91] . It is important to note that, although MALT-derived lymphomas are usually considered to remain confined at the site of origin, in thyroid lymphoma distant relapses occur twice as often as local failure and more than 30% of thyroid lymphomas with localised disease will relapse at a distant site when treated with local therapy alone. Two hundred and eleven patients with stages IE and HE thyroid lymphoma were reviewed in detail in an evaluation of the relative merits of radiotherapy and chemotherapy [125] . Distant and overall relapse rates were significantly lower in the group that received combined-modality treatment (chemotherapy and radiotherapy) than in those given radiotherapy alone. There were also fewer local relapses, but the difference was not statistically significant. Combined-modality treatment, therefore, appears to significantly reduce distant and overall recurrence and should therefore be regarded as the treatment of choice in most patients. The success of chemotherapy alone in both systemic and localised extranodal lymphomas [128] raises the question of the role of radiation. The propensity for patients with thyroid lymphoma to have bulky local disease, however, might be an adverse risk factor for local control with chemotherapy alone, and a 25% recurrence rate has been reported [9, 12] . It would therefore seem that radiation therapy still has a role in the local control of thyroid lymphoma.
E. Primary central nervous system lymphoma
Primary central nervous system lymphoma (PCNSL) is defined as lymphoma arising in and confined to the cranial-spinal axis (brain, eye, leptomeninges and spinal cord). Formerly a rare tumour, PCNSL showed increased incidence both in immunocompromised (congenital, acquired or iatrogenic) high-risk groups and in the general population [129] [130] [131] . PCNSL accounts for l%-2% of malignant brain tumours and 2%-4% of all extranodal lymphomas [1, 2, 23, 131]. Secondary involvement of the CNS occurs in 5%-3O% of systemic non-Hodgkin's lymphoma and is exceedingly rare, but described, in Hodgkin's disease [131] . For the sake of clarity, it should be pointed out here that primary orbital lymphoma represents a different entity and must not be confused with lymphoma of the eye.
Primary lymphoma of the brain
Initial symptoms encompasses signs of increased intracranial pressure, cranial nerve palsies, neurologic deficits and, fairly often, a significant impairment of mental function [130, 131] .
PCNSL is usually disseminated within the nervous system at diagnosis, in approximately 40%-50% of immunocompetent and in nearly 100% of AIDS patients. About 40% of patients have a demonstrable involvement of the spinal fluid and 20% of the eyes. Therefore, in addition to the usual procedures, staging requires contrast-enhanced CT scan and MRI with gadolinium of the brain and orbits, before steroids are started because of the rapid radiographic disappearance of tumour following the administration of steroids ('ghost tumour'), a peculiar feature of PCNSL not shared by any other intracranial malignant tumour. Most typically, PCNSL appears as a mass in the supratentorial white matter, which, with MRI, is isointense or slightly hypointense on Tl-weighted imaging. On both the proton densityweighted and T2-weighted images the central tumour core is relatively iso-to hypointense to surrounding normal brain [130] . An ophthalmologic evaluation with split-lamp examination should also be performed. Histological confirmation is essential, by stereotactic biopsy, lumbar puncture demonstrating a frank positive cytology, or vitreous biopsy [130, 131] . Histologically, the vast majority of lymphomas are of diffuse large B-cell type [129, 130] . No follicular lymphomas have thus far been reported, but cases of T-cell origin have been [132] . Lumbar puncture, besides enabling cytological and routine studies of cerebrospinal fluid (CSF), should comprise a dosage of |32-microglobulin and lactate dehydrogenase. Lymphocyte immunophenotyping and/or polymerase chain reaction for rearrangement of the immunoglobulin heavy chain genes can be performed on the CSF to improve diagnosis [133] .
A surgical procedure more extensive than stereotactic biopsy is rarely indicated. Aggressive surgical decompression with partial or gross total removal of the tumour has benefit (median survival of 1-5 months) [9, 130, 131] . Historically, whole brain radiation has been the treatment of choice, but, despite different radiation schedules with good initial responses, over 90% of patients recur in the brain, often in sites remote from the initial ones [9, 12, 130, 131]. Systemic dissemination occurs in only 10% of the cases. The prognosis for unselected patients with immunocompetent PCNSL treated with irradiation alone is very poor; the five-year survival rate is 5%-10% with a median survival of 12 to 18 months [134] . The addition of spinal axis radiation does not affect survival because it does not prevent cerebral relapse. The results obtained with radiation therapy alone have been poor, so new approaches have been developed. Because of the frequent leptomeningeal involvement, some authors have added intrathecal chemotherapy. On the other hand, several single-institution reports have described encouraging results with systemic chemotherapy alone, with osmotic blood-brain barrier disruption or combined with radiotherapy, with a five-year projected overall survival of 30%-50% and a median survival of 2-3 years [135] [136] [137] [138] [139] [140] [141] [142] . These better results with chemotherapy alone or with combination chemotherapy versus radiation alone might, at least partially, be due to a selection bias for patients with younger age and better performance status. Nevertheless, these trials suggest that the use of cytostatics which penetrate the blood-brain barrier (e.g., high-dose methotrexate or cytarabine) may be able to eradicate the lymphoma. In general, the most recent studies seem to suggest that radiation therapy alone is unable to provide significant long-term survivals -with the possible exception of young patients with small bulk disease-, may interfere with later chemotherapy and may increase the risk of treatment-induced dementia. Evidence is mounting that initial chemotherapy should be the treatment of choice, reserving irradiation for resistant or relapsing disease, however, only randomised trials will be able to clarify this controversial issue.
Primary ocular lymphoma
Primary ocular lymphoma -i.e., restricted to the globe, usually the vitreous, retina, and chorioid -is exceedingly rare. Ocular involvement is bilateral in 80% of cases, even if asymmetric, and more than half of the patients will develop brain lesions after a median of 25 months [143] . Diagnosis of primary ocular lymphoma is difficult. Cytological and immunophenotypic studies of vitreous specimens from vitrectomy can provide the definitive diagnosis, but often they can be inconclusive because of previous topical or, occasionally, systemic corticosteroids due to clinical diagnosis of chronic uveitis or vitritis.
Radiotherapy to both eyes has been the standard treatment, and, as in the other PCNSL, the combination with systemic chemotherapy is being investigated [130, 131, 143, 144] . The addition of intravitreal methotrexate to systemic chemotherapy was recently proposed as a possible means for reducing the long-term side effects of radiotherapy [145] , but this approach is still investigational.
Primary leptomeningeal lymphoma
In rare instances, malignant lymphoma presents as a localised leptomeningeal disease in the absence of parenchymal brain involvement [146] . Diagnosis is commonly made on the basis of positive CSF cytology or meningeal biopsy; detection of a monoclonal lymphocytic population by PCR analysis and flow cytometric studies is helpful. Gadolinium-MRI of the cranial-spinal axis might reveal meningeal enhancement or hydrocephalus [130] . The therapeutical approach is similar to the one for primary brain lymphomas. The survival prognosis is poor despite aggressive treatments.
A completely different type of primary meningeal lymphoma, the primary low-grade lymphoma of the intracranial dura which shows features of a low-grade B-cell MALT lymphoma, has recently been described [147] . In contrast to other types of CNS lymphomas, its prognosis can be very good with radiotherapy possibly combined with chemotherapy. This argues for the importance of its recognition as a distinct clinico-pathological entity.
F. Primary extranodal lymphoma -other sites

Primary extradural lymphoma
Primary extradural lymphoma represents approximately 1% of all localised NHLs; it most often presents with spinal cord compression at thoracic level [I, 12, 23, 148] . The diagnosis is generally obtained at the time of decompressive surgery, with diffuse large-cell lymphoma being the most common histology. MRI is the examination of choice; CSF study results are negative at diagnosis. Data on pattern of relapse are discordant, but CNS relapses seem to be rare [14, 83, 148] . Good results have been obtained with radiotherapy and systemic chemotherapy [12, 148] .
Primary lymphoma of bone
Non-Hodgkin's lymphoma involving bone is relatively common in patients with advanced disease, but constitutes less than 5% of localised extranodal presentations [1, 23, 149] . The most common sites of presentation are the femur and long bones followed by the ileum and scapula. Pain is the usual symptom and radiological findings comprise a lytic and, less commonly, a sclerotic or mixed lesion [23] . The vast majority of the cases are diffuse large B-cell lymphomas in adults and lymphoblastic lymphomas in children [149] [150] [151] . Only a few cases of low-grade histology have been described and they usually have plasmacytoid features [151] ; no follicular lymphomas seem thus far to have been reported. The median age of patients with primary lymphoma of bone is 55 years, but about 3% of all lymphomas in children are localised to bone [150, 152] .
Most patients will present with lymphoma localised to the bone (stage IE), with about one of five presenting regional lymph nodes (stage HE) at diagnosis. Historically, radiotherapy alone has resulted in an overall five-year survival rate of 40%-50% [23, 149, 150] . Most series show no advantage for doses in excess of 40 Gy [23] . Risk factors for loco-regional relapse include large tumour bulk and the use of radiation fields restricted to gross disease with a limited margin [23] .
A combined-modality approach has recently been advocated as the standard therapy in adults [23, 149, 153] . Significantly better survival for adult patients treated by both anthracycline-based chemotherapy and radiation therapy than for those who received radiotherapy alone has been reported in non-randomised studies [153] [154] [155] . At least in adults, long-term follow-up revealed only modest morbidity related to radiation fields [23] . In children, however, the addition of radiotherapy to modern, intense combination chemotherapy may be superfluous, especially in view of its potential for causing serious long-term effects [150] . In a series of 11 children treated with an adriamycin-containing regimen concomitant with radiation therapy (median tumour dose 50 Gy), the overall eight-year actuarial survival was 83% and no relapses were seen, however, two patients developed second bone tumours in the radiation field [152] .
Primary lymphoma of the breast
Primary lymphoma of the breast comprises approximately 2% of all localised extranodal lymphomas [1. 2]. and less than 0.5% of breast tumours. Review of the literature shows two distinct clinicopathologic groups [156, 157] . One, which affects young women, is frequently bilateral, often associated with pregnancy, and it is generally a high-grade malignancy lymphoma [156, 157] . The second group affects older women, presents clinical features identical to epithelial breast cancer. In this second presentation, the most common histology is the diffuse large B-cell type [23, 156, 157] . However, a few cases of low-grade lymphomas have been described [157] ; some of MALT origin have been reported in the Western world [95, 136, 156, 158] .
The lymphoma usually presents with a breast mass, frequently rather large, with or without ipsilateral adenopathy. Lymphomatous involvement of the breast is generally depicted on the mammogram as a circumscribed mass without tumour calcifications [9] . Its appearance, however, is generally non-specific, compromising an accurate diagnosis, which requires fine-needle aspiration cytology or biopsy. Historically, radiotherapy to the breast and the regional lymph nodes has been employed following surgery. With doses of 35-40 Gy, local control is achieved in four of five patients and overall survival rates of 40%-60% at 10 years are reported [23] . Despite good local control, systemic failure occurs in at least half of the patients. Prognostic factors for disease progression include large tumour bulk and nodal involvement. Combined modality treatment has most recently been recommended [159, 160] . Long-term results with the addition of combination chemotherapy are still sparse and therefore the relative merits of this modality can as yet not be assessed. It would, however, seem reasonable to treat these patients according to the histology. Therefore radiation alone should not be given to the diffuse large cell lymphomas but might have a role in the rare localised indolent lymphomas of follicular or MALT type.
Primary lymphoma of the lung
While lung is frequently involved by disseminated lymphoma, isolated pulmonary lymphoma is rare, accounting for less than 1% of all extranodal localised disease [23] .
Three categories of primary pulmonary lymphoma can be distinguished: in rare instances, large-cell lymphoma can present primarily in the lung [23, 161] ; a second variant is represented by T-cell lymphoma presenting as an angiocentric process within the framework of the lethal midline granuloma [110] . However, the most common histologic type is represented by lowgrade MALT lymphoma, often in the past considered as a pseudotumour because of its long indolent natural history. Principles of treatment vary with histology. The MALT type lesions should be treated like localised, lowgrade lymphomas [23] . However, difficulties with safe delivery of irradiation to the lungs often lead to individualised therapy with not well documented results.
Other primary lymphomas of the upper airways
Tracheal involvement usually occurs with disseminated lymphoma. Primary tracheal lymphoma is a rare entity. Reported histologies are varied, with a predominance of low-grade lesions, sometimes including lymphomas of MALT type [162] . The therapeutic approach for localised disease should comprise combined chemoradiotherapy [162] . Primary laryngeal lymphomas are also very rare and may arise from the MALT [163] .
Primary splenic lymphoma
The spleen is frequently involved by Hodgkin's and nonHodgkin's lymphomas of nodal type and by acute and chronic leukaemias during the course of these diseases. About 20% of nodal non-Hodgkin's lymphomas show evidence of spleen involvement at presentation. However, primary lymphomas of the spleen are quite uncommon. Several cases of low-grade lymphoma involving the marginal zone of the splenic white pulp have merited particular attention in the recent literature [4, 164] . Most of these cases appear to have the characteristics of the marginal zone B-cell lymphoma [4] . An entity related to this one is the splenic lymphoma with circulating villous lymphocytes [165, 166] . Some investigators believe that it corresponds to the leukemic phase of the marginal zone B-cell lymphoma [4, 167] . Further studies are also required to definitely clarify the relationship between the splenic marginal zone B-cell lymphoma and the nodal (monocytoid) and extranodal (MALT-type) B-cell lymphomas of the marginal zone [4, 168] . Patients, typically in advanced age, present with splenomegaly, sometimes with bone marrow and peripheral blood involvement without lymphoadenopathy. A serum monoclonal gammopathy is often detectable, together with anemia and thrombocytopenia, mostly due to the hypersplenism. Treatment depends on symptomatic splenomegaly and white cell count. In our opinion, a wait-and-see policy may be followed in several instances, as in other lowgrade B-cell malignancies. Splenectomy is indicated to correct the hypersplenism and related cytopenia and in cases of splenic lymphoma with villous lymphocytes with rapidly rising white cell counts. The role of chemotherapy is uncertain [166, 169] .
Together with the liver, spleen is the primary site of involvement of the rare hepatosplenic gamma/delta T-cell lymphoma. This disease affects young patients who present marked hepatosplenomegaly, commonly with bone marrow involvement and without lymphadenopathy or significant peripheral blood lymphocytosis. The clinical course is usually very aggressive, with a median survival of less than one year despite the possibility of initial response to multiagent chemotherapy [170] .
Primary lymphoma of the liver
Liver involvement by lymphoma is relatively common and usually indicates advanced disease. However, primary lymphoma of the liver is exceedingly rare, with less than 100 cases reported in the literature [171] . A possible pathogenetic role of hepatitis B and C viruses has been proposed, but thus far there has not been enough evidence to support these viruses as important etiologic factors [171] . It typically occurs in the fifth decade with a male predominance. The majority of the cases have diffuse large B-cell histologies, but peripheral T-cell lymphomas and primary low-grade MALT lymphomas have also been reported [172, 173] .
Presentation may mimic hepatocellular carcinoma, since primary liver lymphoma may present as single or multiple masses or even as a diffuse infiltration that may manifest itself as various liver diseases, or very occasionally as fulminant hepatic failure [172, 174] . The disease is often associated with several poor-prognosis characteristics, i.e., advanced age, bulky disease, aggressive histology. It is difficult to make general treatment recommendations for such a rare type of lymphoma. Partial hepatectomy for solitary lesions has been proposed [172] , but given the commonly registered extensive intrahaepatic disease, adjuvant systemic chemotherapy seems to be mandatory. For most patients who present with adverse prognostic factors combination chemotherapy with or without radiotherapy appears the most appropriate strategy.
Primary lymphoma of the gallbladder
Primary malignant lymphoma of the gallbladder is exceedingly rare; only nine well documented cases have been reported in the English-language literature [175] . The histology can be variable, and occasional cases of MALT lymphomas have been reported. [176] . The possible growth of malignant lymphoma in the biliary ducts has also been described [177] .
Primary lymphoma of the oesophagus
Although lymphoma may involve any part of the gastro-intestinal tract, either primarily or secondarily, oesophageal involvement is exceedingly rare [178] . Only a few cases have been reported in the literature: diagnosis is generally biopsy-related, since roentgenographic studies and endoscopic findings are unspecified. No exact therapeutic rules have been established, but combined radio-chemotherapy seems advisable [178] .
Primary cardiac lymphoma
Primary malignant lymphomas of the heart are extremely rare [179] . In a series of more than 500 primary tumours and cysts of the heart, only seven were primary lymphomas [180] . These tumours present with a variety of clinical manifestations and very rarely are diagnosed ante mortem.
Primary adrenal lymphoma
Adrenal involvement in disseminated lymphoma is a relatively common occurrence, however involvement of the adrenal glands as the sole manifestation of lymphoma is very rare, with approximately 70 cases reported in the literature over the past 40 years. The true incidence of this neoplasm is not known. Most of the cases appear to be of B-cell origin with diffuse large cell histology.
The disease is often bilateral. The presenting symptoms are non-specific and may be related to lymphoma or to an associated adrenal insufficiency that may be a lethal complication. Long delays between the onset of symptoms and the diagnosis are frequent. In clinically silent cases, adrenal insufficiency may be latent and the disease revealed as an adrenal mass incidentally discovered by diagnostic imaging [181, 182] .
Primary lymphoma of soft tissues
Non-Hodgkin's lymphomas of various histologic subtypes, usually diffuse large B-cell (centroblastic) lymphoma, have been described in some soft tissues [183] . This localisation is very rare, however, with an incidence not exceeding 2% of all soft tissue tumours. In differential diagnosis undifferentiated metastatic carcinomas and round-cell sarcomas have to be considered, and immunohistochemistry studies are often decisive for the final diagnosis. Intermuscular tissue is the most common localisation but primary skeletal muscle involvement is also well described [184] . NHLs have been described also in post-mastectomy lymphoedema and in juxta-articular tissues after prosthetic joint replacement [185, 186] .
Primary body-cavity-based lymphomas (primary-effusion lymphoma andpyothorax-associated lymphoma)
Primary-effusion lymphoma and pyothorax-associated lymphoma are two distinct extranodal lymphomas, showing a particular tropism for body cavities, i.e., pleural, peritoneal or pericardial spaces.
Primary-effusion lymphoma is a recently-described entity with particular epidemiological, molecular and clinical features [187] . It occurs predominantly in HIVinfected individuals, representing 3% of all NHLs, but it has been reported even in HIV-seronegative cases (less than 1% of all high-grade NHLs) [188, 189] . Median age at presentation is approximately 40 years in HIV-positive cases and nearly 80 years in seronegative patients. AIDS-related primary-effusion lymphoma usually occurs in very severely immunodeficient persons and tends to be a later manifestation of the HIV infection. Histological features comprise immunoblastic or anaplastic cells, immunophenotypically related to a late stage of B-cell activation toward terminal plasma cell differentiation [190] . DNA sequences from Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) and from EBV are detectable in tumour cells of the large majority of cases, with the last virus apparently less closely associated with immunocompetent cases [189] . Primary-effusion lymphoma typically presents as lymphomatous effusions (pleural, pericardial, or ascitic) usually without a solid tumour mass. Its prognosis appears to be dismal and, because of the small number of reported cases, no exact treatment rules can be given.
Pyothorax-associated lymphoma, principally reported in Japan, affects elderly patients with a longer than 20-year history of pyothorax, usually related to chronic tuberculosis [191] . Histologically, this extranodal lymphoma is usually of the immunoblastic B-cell type. EBV genome is found in the lymphoma cells in approximately 85% of the cases [191] . In contrast to primary-effusion lymphoma, KSHV/HHV-8 DNA is usually absent and clinical manifestations always comprise a neoplastic mass associated with the pleural effusion [192] .
Angiotropic lymphoma
Angiotropic (intravascular) lymphoma is a rare disease. Most cases are of diffuse large B-cell type, but there are a few with T-cell phenotype [193, 194] . Neoplastic cells typically grow trapped within small arteries, veins and capillaries, and, only rarely, extravasate. Presenting clinical features are varied, often comprising bizarre neurologic symptoms and non-specific cutaneous manifestations. Angiotropic lymphoma should always be considered as being Ann Arbor Stage IV and treated with systemic chemotherapy. The large number of cases reported post-mortem attests the difficulty in obtaining the correct diagnosis; however, the prognosis for the properly treated cases seems to be similar to that of the other diffuse large-cell lymphomas.
Lymphomas arising from the thymus
Primary mediastinal large B-cell lymphoma with sclerosis may derive from a special thymic medullary B-cell population. This view is based mainly on the location and on the frequent persistence of thymic epithelial structure. It should not be surprising that the major organ of T-cell development may be the site of a B-cell lymphoma, since recent evidence has shown the presence of a significant B-cell population in the thymic medulla [195] . Primary mediastinal large B-cell lymphoma is a distinct clinicopathological entity [4, 196] , with a recently reported high frequency of specific chromosomal gain (e.g., chromosome 9p) not known for other NHLs [197] . It more frequently affects young women. Symptoms at presentation are usually due to a large mediastinal mass which frequently invades lungs, superior vena cava, pericardium, pleura and chest wall. Despite this local aggressiveness, distant spread is relatively uncommon, and is more likely to be extranodal, including kidneys, liver, gastrointestinal tract, ovaries and CNS. Involvement of the bone marrow is unusual. There are conflicting data regarding the overall prognosis, the response to chemotherapy and the need of irradiation [198] [199] [200] . However, consolidation radiotherapy to the bulky site appears beneficial in most of the reported series, suggesting that the control of intrathoracic disease is essential. Therefore, combination of aggressive chemotherapy and mediastinum irradiation must be considered the standard therapeutic approach, at least until randomised trials show equivalence of chemotherapy alone. [201] . Despite the good results of myeloablative chemotherapy followed by autologous stem cell transplantation reported in a recent series [202] , in our opinion this strategy, as first-line therapy, should still be considered investigational.
In addition, very few cases of primary low-grade B-cell MALT lymphoma have been reported in the thymus. It can mimic myoepithelial sialadenitis or be preceded by a prolonged history of Sjogren's syndrome [203, 204] .
